Cell and gene therapies
-
Clinicians ready for myeloma ‘cure’
- 14 Sep 2022
CAR-T is coming in multiple myeloma, says a leading haematologist, while flagging another new class of therapies is ‘hot on its heels’.
Read more -
-
Unlocking the value of genomics
- 13 Dec 2021
Industry genomics alliance InGeNA has released two reports that move to demonstrate the opportunity of genomics, including the value of intervention.
Read more -
Chinese pharma’s gene therapy trial
- 24 Nov 2021
A genetically modified viral treatment for cancer is the tenth GMO product to seek OGTR approval this year.
Read more -
Aust looks to cell and gene ‘runway’
- 27 Oct 2021
Industry consortium launches RM ‘roadmap’, now looking to establish a ‘Catalyst’ to capitalise on a $6B annual opportunity.
Read more -
First RNA therapy debuts at TGA
- 20 Oct 2021
Gains orphan drug designation, marking the first regulatory appearance of a US biotech with an exciting RNAi pipeline.
Read more -
PBAC passes its first gene therapy
- 18 Oct 2021
UPDATED: ‘There is considerable work to be done’, says Novartis, while calling for the process to continue to evolve for innovative therapies .
Read more -
Third CAR-T gets MSAC nod
- 15 Oct 2021
Funding of Gilead’s Tecartus gets a fast recommendation from MSAC just a few months after its TGA approval.
Read more